MOH

Molina Healthcare, Inc. Health Care Hospital & Medical Service Plans Russell 3000
$204.78Close $10.4BMarket cap $122.65 – $242.8852-week range Mid-januaryNext report · estimated

Highlights

Cautions

  • Trend not confirmed 7 of 8 conditions · RS under 70
  • Earnings shrinking EPS −51% year on year

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 22, 2026
Off 12-month high 16%
1wk down 2.1% price change
1mo up 8.3% price change
12-month return up 36% market up 11% · its own up 17%
F-score 4 / 9 Weak
Altman Z″ 3.60 Low risk
P/E 22.1× price / earnings
PEG — P/E / EPS growth
P/B 2.6× price / book
Earnings yield up 7.8% EBIT / enterprise value
Cheaper than 53% of the market · around average
Revenue growth up 12% year on year
EPS growth down 51% latest quarter · +24 pts
Sales growth down 3% latest quarter · +1 pts
ROE up 11% return on equity
Free cash margin down 1% -$636.0M FCF
D/E 0.93 long-term debt / equity
Net debt / EBITDA -0.5× net cash
Interest cover —EBIT / interest
Piotroski tests
  • operating cash flow is negative
  • profitability slipped from last year
  • profits not fully backed by cash
  • took on more long-term debt
  • gross margin narrowed
  • profitable on its assets
  • short-term liquidity improved
  • no new shares issued
  • assets working harder

Trade setup

ATR% 4.4% $9.07 a day · 2×ATR $186.64
RS 65 / 99 vs the universe
Trend 7 / 8 RS under 70
Relative volume 2.5× vs 50-day average
Up/down volume 1.01 50 sessions
Implied move — no scheduled report
Trend template · 7 of 8
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

3 flagged
  • Material impairment The company disclosed a material impairment - an asset written down below the value the balance sheet had been carrying.
  • Profit not backed by cash Reported profit of $472.0M came with -$535.0M of operating cash flow. Profit that cash does not follow is the classic signature of aggressive accounting.
  • Gross margin narrowing Gross margin fell from 15.3% to 13.1%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Oct 21, 2026
Results reaction Oct 21, 2026-1% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $45.4B +12% on FY2024
$0 $50B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $19.4B FY2021 · $27.8B FY2022 · $32.0B FY2023 · $34.1B FY2024 · $40.6B FY2025 · $45.4B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $472.0M -60% on FY2024
$0 $2B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $673.0M FY2021 · $659.0M FY2022 · $792.0M FY2023 · $1.1B FY2024 · $1.2B FY2025 · $472.0M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology -$636.0M down to a loss
-$1B $0 $2.5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.8B FY2021 · $2.0B FY2022 · $682.0M FY2023 · $1.6B FY2024 · $544.0M FY2025 · -$636.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 13%
  • Net 1%
  • Free cash -1%
0% 20% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 13% · Net 3% · Free cash 9% FY2021 · Gross 15% · Net 2% · Free cash 7% FY2022 · Gross 15% · Net 2% · Free cash 2% FY2023 · Gross 16% · Net 3% · Free cash 5% FY2024 · Gross 15% · Net 3% · Free cash 1% FY2025 · Gross 13% · Net 1% · Free cash -1%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $482.0M net cash
  • Cash
  • Long-term debt
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $4.2B · Long-term debt $2.1B FY2021 · Cash $4.4B · Long-term debt $2.2B FY2022 · Cash $4.0B · Long-term debt $2.2B FY2023 · Cash $4.8B · Long-term debt $2.2B FY2024 · Cash $4.7B · Long-term debt $2.9B FY2025 · Cash $4.2B · Long-term debt $3.8B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 51m -13.6% since FY2020
59m 51m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 59m FY2021 · 58m FY2022 · 58m FY2023 · 58m FY2024 · 56m FY2025 · 51m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $19.4B $27.8B $32.0B $34.1B $40.6B $45.4B
Gross margin 13% 15% 15% 16% 15% 13%
Operating income $1.1B $1.0B $1.2B $1.6B $1.7B $781.0M
Net income $673.0M $659.0M $792.0M $1.1B $1.2B $472.0M
Net margin 3% 2% 2% 3% 3% 1%
Earnings per share $11.24 $11.25 $13.54 $18.78 $20.43 $8.92
Free cash flow $1.8B $2.0B $682.0M $1.6B $544.0M -$636.0M
Free cash margin 9% 7% 2% 5% 1% -1%
Cash $4.2B $4.4B $4.0B $4.8B $4.7B $4.2B
Long-term debt $2.1B $2.2B $2.2B $2.2B $2.9B $3.8B
Shareholders' equity $2.1B $2.6B $3.0B $4.2B $4.5B $4.1B
Shares outstanding 59m 58m 58m 58m 56m 51m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 22, 2026 Quarterly ↗ Sep 30, 2026 22d
Jul 23, 2026 Quarterly ↗ Jun 30, 2026 23d
Apr 23, 2026 Quarterly ↗ Mar 31, 2026 23d
Feb 10, 2026 Annual ↗ Dec 31, 2025 41d
Oct 23, 2025 Quarterly ↗ Sep 30, 2025 23d
Jul 24, 2025 Quarterly ↗ Jun 30, 2025 24d
Apr 24, 2025 Quarterly ↗ Mar 31, 2025 24d
Feb 11, 2025 Annual ↗ Dec 31, 2024 42d
Oct 24, 2024 Quarterly ↗ Sep 30, 2024 24d
Jul 25, 2024 Quarterly ↗ Jun 30, 2024 25d
Apr 25, 2024 Quarterly ↗ Mar 31, 2024 25d
Feb 13, 2024 Annual ↗ Dec 31, 2023 44d

Current reports